PMID- 37462429 OWN - NLM STAT- MEDLINE DCOM- 20240104 LR - 20240301 IS - 1529-7535 (Print) IS - 1529-7535 (Linking) VI - 25 IP - 1 DP - 2024 Jan 1 TI - Venovenous Extracorporeal Membrane Oxygenation Initiation for Pediatric Acute Respiratory Distress Syndrome With Cardiovascular Instability is Associated With an Immediate and Sustained Decrease in Vasoactive-Inotropic Scores. PG - e41-e46 LID - 10.1097/PCC.0000000000003325 [doi] AB - OBJECTIVE: To determine the association of venovenous extracorporeal membrane oxygenation (VV-ECMO) initiation with changes in vasoactive-inotropic scores (VISs) in children with pediatric acute respiratory distress syndrome (PARDS) and cardiovascular instability. DESIGN: Retrospective cohort study. SETTING: Single academic pediatric ECMO center. PATIENTS: Children (1 mo to 18 yr) treated with VV-ECMO (2009-2019) for PARDS with need for vasopressor or inotropic support at ECMO initiation. MEASUREMENTS AND MAIN RESULTS: Arterial blood gas values, VIS, mean airway pressure (mPaw), and oxygen saturation (Sp o2 ) values were recorded hourly relative to the start of ECMO flow for 24 hours pre-VV-ECMO and post-VV-ECMO cannulation. A sharp kink discontinuity regression analysis clustered by patient tested the difference in VISs and regression line slopes immediately surrounding cannulation. Thirty-two patients met inclusion criteria: median age 6.6 years (interquartile range [IQR] 1.5-11.7), 22% immunocompromised, and 75% had pneumonia or sepsis as the cause of PARDS. Pre-ECMO characteristics included: median oxygenation index 45 (IQR 35-58), mPaw 32 cm H 2o (IQR 30-34), 97% on inhaled nitric oxide, and 81% on an advanced mode of ventilation. Median VIS immediately before VV-ECMO cannulation was 13 (IQR 8-25) with an overall increasing VIS trajectory over the hours before cannulation. VISs decreased and the slope of the regression line reversed immediately surrounding the time of cannulation (robust p < 0.0001). There were pre-ECMO to post-ECMO cannulation decreases in mPaw (32 vs 20 cm H 2o , p < 0.001) and arterial P co2 (64.1 vs 50.1 mm Hg, p = 0.007) and increases in arterial pH (7.26 vs 7.38, p = 0.001), arterial base excess (2.5 vs 5.2, p = 0.013), and SpO 2 (91% vs 95%, p = 0.013). CONCLUSIONS: Initiation of VV-ECMO was associated with an immediate and sustained reduction in VIS in PARDS patients with cardiovascular instability. This VIS reduction was associated with decreased mPaw and reduced respiratory and/or metabolic acidosis as well as improved oxygenation. CI - Copyright (c) 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. FAU - Chilcote, Daniel AU - Chilcote D AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Sriram, Anant AU - Sriram A AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Slovis, Julia AU - Slovis J AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Morgan, Ryan W AU - Morgan RW AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Schaubel, Douglas E AU - Schaubel DE AD - Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. FAU - Connelly, James AU - Connelly J AD - ECMO Center, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Berg, Robert A AU - Berg RA AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Keim, Garrett AU - Keim G AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Yehya, Nadir AU - Yehya N AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Kilbaugh, Todd AU - Kilbaugh T AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. AD - ECMO Center, The Children's Hospital of Philadelphia, Philadelphia, PA. FAU - Himebauch, Adam S AU - Himebauch AS AD - Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, PA. AD - ECMO Center, The Children's Hospital of Philadelphia, Philadelphia, PA. LA - eng GR - R01 HL147616/HL/NHLBI NIH HHS/United States GR - RL1 HD107777/HD/NICHD NIH HHS/United States GR - K23 HL153759/HL/NHLBI NIH HHS/United States GR - K23 HL148541/HL/NHLBI NIH HHS/United States GR - R01 HL148054/HL/NHLBI NIH HHS/United States GR - R01 DK070869/DK/NIDDK NIH HHS/United States PT - Journal Article DEP - 20230718 PL - United States TA - Pediatr Crit Care Med JT - Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies JID - 100954653 SB - IM MH - Humans MH - Child MH - *Extracorporeal Membrane Oxygenation MH - Retrospective Studies MH - *Respiratory Distress Syndrome/therapy MH - *Respiratory Insufficiency/therapy MH - Arteries PMC - PMC10768839 MID - NIHMS1910748 COIS- Dr. Keim received an institutional grant. Grant funding was paid to the affiliated institutions in support of the ongoing work of Drs. Morgan (National Institutes of Health [NIH] National Heart, Lung, and Blood Institute [NHLBI] K23-HL148541), Berg (NIH 5R01HL147616-03, NIH 1RL1HD107777-01), Yehya (NIH NHLBI 5R01HL148054-03), Schaubel (NIH NIDDK R01-DK070869), and Himebauch (NIH NHLBI K23-HL153759). Dr. Himebauch's institution received funding from the NHLBI. Drs. Himebauch, Sriram, and Morgan received support for article research from the NIH. Dr. Sriram's institution received funding from the NHBLI (K23-HL153759). Dr. Morgan's institution received funding from the NHBLI (K23HL148541). Dr. Yehya's institution received funding from Pfizer. The remaining authors have disclosed that they do not have any potential conflicts of interest. EDAT- 2023/07/18 13:07 MHDA- 2024/01/04 11:43 PMCR- 2025/01/01 CRDT- 2023/07/18 09:33 PHST- 2025/01/01 00:00 [pmc-release] PHST- 2024/01/04 11:43 [medline] PHST- 2023/07/18 13:07 [pubmed] PHST- 2023/07/18 09:33 [entrez] AID - 00130478-202401000-00017 [pii] AID - 10.1097/PCC.0000000000003325 [doi] PST - ppublish SO - Pediatr Crit Care Med. 2024 Jan 1;25(1):e41-e46. doi: 10.1097/PCC.0000000000003325. Epub 2023 Jul 18.